E. Davies et al., SOMATIC MUTATIONS OF THE ANGIOTENSIN-II (AT(1)) RECEPTOR GENE ARE NOTPRESENT IN ALDOSTERONE-PRODUCING ADENOMA, The Journal of clinical endocrinology and metabolism, 82(2), 1997, pp. 611-615
Angiotensin II stimulates aldosterone secretion from the adrenal zona
glomerulosa and mediates most of its biological effects via G protein-
coupled type 1 angiotensin II receptors (AT(1)). A number of G protein
-coupled receptors are constitutively activated as a result of somatic
mutations in the gene encoding the protein. It is, therefore, possibl
e that primary hyperaldosteronism caused by an aldosterone producing a
denoma (APA) may be the result of constitutive activation of the AT(2)
receptor. The 1.1-kilobase coding region (exon 5) of the AT(1) recept
or gene was analysed in APA and normal adrenal tissue for the presence
of mutations using single stranded conformational polymerphism and se
quencing techniques. In 17 APAs, no functional mutations were found th
at could account for the observed pathophysiology. However, three sile
nt polymorphisms were detected in regions encoding the second extracel
lular loop, the intracellular arm preceding the COOH terminal, and the
3'-untranslated region. In conclusion, somatic mutations in the codin
g region of the AT(1) receptor gene do not appear to play a role in pr
imary hyperaldosteronism caused by an APA.